ARCHIVES

Alimta Granted Approval As NSCLC Continuation Therapy

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

Sprycell Approved for CML

November 5, 2010

ASCO Sees Efforts Pay Off In Health Care Reform: Clinical Trials

October 1, 1993

Adamson, Henney Chair Silicone Task Force

April 25, 1992

Neutron Therapy Contracts Wind Down Next Year; DCT To Consider Whether To Continue Support

March 25, 1988

Southern Screening Contract Now at $2 Mil. Year For Five Year

June 7, 1974

NCI to Implement Plan For Stepped Up Patient Accrual Despite Reservations OF Group Chairmen

December 4, 1987